Clinical trials
Breast Neoplasms trials in Nigeria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Chicago | 4 |
| Chinese University of Hong Kong | 2 |
| ETOP IBCSG Partners Foundation | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Ikechukwu Bartholomew Ulasi | 1 |
| International Atomic Energy Agency | 1 |
| International Breast Cancer Research Foundation | 1 |
| Lagos State University | 1 |
| Northwestern University | 1 |
| Obafemi Awolowo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 20 |
| Postoperative Pain | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Chronic Pain | 1 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplastic Cells, Circulating | 1 |
| Prostatic Neoplasms | 1 |
| Rectal Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.